| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d1c5567f986eff6f2f7d84c5549367f1 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-397
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 |
| filingDate |
2014-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5786d9659ad28327e18525ca2657cd02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_545e1d46479107859d2a09002026cd04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e13c6a6734c79915ea83da571b120606
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a6a366fef4b74896c0dc5f0b3806ee5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27de14f017c62702932dc852ae7614c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3ef4276afbc6277b69a47a10d3d0fe3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a0222179940ebc9a846d2abffc0b5f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd1131f7e02d1c9d05e987418c3a7d91 |
| publicationDate |
2015-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2015093859-A1 |
| titleOfInvention |
Pharmaceutical combined preparation containing hmg-coa reductase inhibitor and cholesterol absorption inhibitor |
| abstract |
The present invention provides a pharmaceutical combined preparation capable of remarkably improving the convenience of drug administration to a patient since two types of drugs (HMG-CoA reductase inhibitor and cholesterol absorption inhibitor) are simultaneously contained and the dissolution pattern of the two types of drugs is the same as that of a single preparation of each drug when the combined preparation is dissolved. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3243506-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017194432-A1 |
| priorityDate |
2013-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |